Research Highlights Relationship Between Nonalcoholic Steatohepatitis and Heart Health
Free-Photos / Pixabay

Research Highlights Relationship Between Nonalcoholic Steatohepatitis and Heart Health

According to a story from Health Canal, a team of researchers led by Dr. Mohammad Siddiqui of Virginia Commonwealth University (VCU) recently released a study which further highlights the relationship…

Continue Reading Research Highlights Relationship Between Nonalcoholic Steatohepatitis and Heart Health
Researchers Awarded Prize for the Development of Vital Treatment for Spinal Muscular Atrophy
AxxLC / Pixabay

Researchers Awarded Prize for the Development of Vital Treatment for Spinal Muscular Atrophy

According to a story from the Farmington Daily Times, Dr. C. Frank Bennett, who grew up in Aztec, NM, and his collaborator Dr. Adrian Krainer, were both jointly awarded the…

Continue Reading Researchers Awarded Prize for the Development of Vital Treatment for Spinal Muscular Atrophy
Decorated Admiral in the Center of President Trump Spat is Battling a Rare Form of Cancer
Source: Pixabay.com

Decorated Admiral in the Center of President Trump Spat is Battling a Rare Form of Cancer

You might have heard of the recent political situation where President Donald Trump criticized retired Adm. William H. McRaven on a number of issues. We're not going to dig into…

Continue Reading Decorated Admiral in the Center of President Trump Spat is Battling a Rare Form of Cancer
Iowa Doctors Hesitant to Certify Medical Cannabis Patients
https://pixabay.com/en/marijuana-colorado-marijuana-grow-269851/

Iowa Doctors Hesitant to Certify Medical Cannabis Patients

According to the Des Moines Register, Iowa has a new medical marijuana program rolling out on December 1st, but many doctors in the state have reservations about enrolling patients. Iowa's…

Continue Reading Iowa Doctors Hesitant to Certify Medical Cannabis Patients

Working to Improve Gene Therapy for Adrenoleukodystrophy and Other Rare Conditions

Rare disease research is often underrepresented in the field of science. However, recent developments have made researchers more interested in studying this group of diseases. For instance, investments in gene…

Continue Reading Working to Improve Gene Therapy for Adrenoleukodystrophy and Other Rare Conditions
First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA
frolicsomepl / Pixabay

First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA

According to a story from BioSpace, the biopharmaceutical company Sobi and the biotechnology company NovImmune SA have recently announced that the US Food and Drug Administration (FDA) has approved Gamifant,…

Continue Reading First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA
Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease
Source: Pixabay.com

Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease

According to a story from the biotechnology company Amgen, a review from the European Medicines Agency (EMA) has recommended that the indication for blinatumomab, marketed as BLINCYTO®, be expanded. The…

Continue Reading Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease
I Needed to Accept Change to Better Cope with Dystonia
https://pixabay.com/en/daisies-flower-spring-plant-nature-388946/

I Needed to Accept Change to Better Cope with Dystonia

In 2001, I developed severe chronic pain from a neurological movement disorder called dystonia. My life before and after dystonia are as different as night and day. I went from a very active lifestyle to…

Continue Reading I Needed to Accept Change to Better Cope with Dystonia
Potential Treatment for Niemann-Pick Disease is Granted Orphan Drug Designation in the EU
Etereuti / Pixabay

Potential Treatment for Niemann-Pick Disease is Granted Orphan Drug Designation in the EU

According to a story from rdmag.com, the biopharmaceutical company IntraBio Inc., recently announced that its IB1000 series of investigational therapeutic compounds have been granted Orphan Medicinal Drug Designation as a…

Continue Reading Potential Treatment for Niemann-Pick Disease is Granted Orphan Drug Designation in the EU